Phase 1b/2 study to assess the safety, tolerability, and clinical activity of BGB-290 in combination with temozolomide in patients with locally advanced or metastatic solid tumors

Authors :: R. Wei
Melissa Lynne Johnson
B. Benson
R. Brachmann
Matthew D. Galsky
Source :: Annals of Oncology. 28:v139-v140
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
Temozolomide
business.industry
Internal medicine
medicine
Locally advanced
Safety tolerability
In patient
Hematology
business
medicine.drug

Tools